| [1] |
GUO Shuhuan, GAO Yali, CHEN Jingge.
Effect of miR-132-3p on epithelial-mesenchymal transition of trophoblast cells by targeting the SIRT1/NF-κB pathway
[J]. Basic & Clinical Medicine, 2025, 45(12): 1565-1571.
|
| [2] |
CHEN Qingxia, LIANG Yuling, LUO Yalan, NIU Bin.
Inhibition of NRF1/ABCC1 improves chemosensitivity of human lung adenocarcinoma cell lines to cisplatin
[J]. Basic & Clinical Medicine, 2025, 45(1): 51-59.
|
| [3] |
LI Shunle, LI Rong, TIAN Yaya, RAN Xiaoli, ZHAO Yanpei, XU Meng.
Association of serum KLF5 and actinin-4 levels with prognosis of TACE treatment for hepatocellular carcinoma
[J]. Basic & Clinical Medicine, 2024, 44(9): 1284-1289.
|
| [4] |
ZHAO Junli, ZHU Junjun, ZHAN Qiunan, LIU Miao.
Bone marrow mesenchymal stem cell-derived exosome inhibits high glucose-induced EMT of peritoneal mesothelial cells
[J]. Basic & Clinical Medicine, 2024, 44(8): 1149-1156.
|
| [5] |
WANG Tingting, WEI Huan, YANG Yongli, ZHOU Xian, HU Yang.
Nervous protection provided by notoginsenoside Rg1 in rat model with Alzheimer′s disease
[J]. Basic & Clinical Medicine, 2024, 44(8): 1094-1100.
|
| [6] |
LU Huiying, WANG Jianguo.
Downregulation of demethylase FTO inhibits proliferation of human liver cancer cell line HepG2
[J]. Basic & Clinical Medicine, 2024, 44(2): 185-191.
|
| [7] |
FAN Ying, LIU Yang, LIU Yanyong.
Research progress on protein translational reprogramming in tumors
[J]. Basic & Clinical Medicine, 2024, 44(12): 1736-1740.
|
| [8] |
CAO Peiqian, WANG Zhigang, MIAO Xuehong.
Diammonium glycyrrhizinate alleviates lung injury in rat models with lung tuberculosis
[J]. Basic & Clinical Medicine, 2024, 44(11): 1544-1550.
|
| [9] |
WANG Chunyan, WANG Ping, SONG Longfei, LIU Yongquan, MAN Jun.
Effects of lncRNA FEZF1-AS1 on proliferation, migration and invasion through regulating EZH2 of lung interstitial cells
[J]. Basic & Clinical Medicine, 2024, 44(1): 43-50.
|
| [10] |
Yimamaimaitijiang·ABRA, Pakhardin·BAIKERE, YI Chao, TONG Qing.
Clinical value of plasma hsa_circ_005230 in the diagnosis and prognosis evaluation of primary hepatocellular carcinoma
[J]. Basic & Clinical Medicine, 2023, 43(9): 1417-1422.
|
| [11] |
LIN Yingxue, CUI Haipeng, WANG Aiguo, YAO Yinhui, ZHAO Juan.
Rapamycin alleviates hepatocellular carcinoma progressing in transgenic mice
[J]. Basic & Clinical Medicine, 2023, 43(8): 1241-1246.
|
| [12] |
ZOU Jin, HE Xianglei, ZHANG Xin, CHEN Riping, ZHANG Yu, HU Shuaiyue, YING Shibo.
Expression of chemical modification enzymes PADs and PRMTs targeting protein arginine residues in human hepatocellular carcinoma cell lines
[J]. Basic & Clinical Medicine, 2023, 43(6): 898-903.
|
| [13] |
JI Mengdie, YUAN Zan, BIAN Xiaocui, YANG Yurong, GUO Xin, WANG Qi, CHEN Yang.
Analysis of genomic copy number variations in human hepatocellular carcinoma cell lines HepG2 and Huh7
[J]. Basic & Clinical Medicine, 2023, 43(6): 960-966.
|
| [14] |
XU Qian, DUAN Hua, GAN Lu, LIU Qiwei.
Research progress of RhoGTPase activating protein in epithelial-mesenchymal transition
[J]. Basic & Clinical Medicine, 2023, 43(2): 301-305.
|
| [15] |
LIU Aixia, ZHANG Hao, SUN Jie, YANG Lihua, ZHAO Xiaotao.
The role of GPS2 in regulating proliferation, migration and invasion of hepatocellular carcinoma cell line MHCC-97H
[J]. Basic & Clinical Medicine, 2023, 43(12): 1784-1791.
|